脂质缺乏有助于衰老和异常性肺纤维化中的膜原生细胞功能受损
Jiurong Liang1, Guanling Huang1, Xue Liu1
1Department of Medicine and Women's Guild Lung Institute, and.
American journal of respiratory cell and molecular biology
|April 24, 2024
概括
异形性肺纤维化 (IPF) 涉及到肺前细胞中脂肪代谢受损. 在膜II型细胞 (AEC2s) 中恢复脂质平衡可能会改善肺部修复,并提供新的IPF疗法.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 代谢研究研究 代谢研究
背景情况:
- 异形性肺纤维化 (IPF) 是一种与衰老相关的肺部疾病,其特征是上皮损伤和修复不良.
- 膜II型细胞 (AEC2s) 是肺部维护和再生的关键原生细胞.
- 功能障碍的AEC2s有助于IPF的发病.
研究的目的:
- 从IPF患者和老年,受伤的小鼠模型中研究AEC2中的脂质代谢.
- 为了确定衰老对AEC2脂质代谢和修复能力的影响.
- 探索调节AEC2s中的脂质代谢的治疗潜力.
主要方法:
- 单细胞RNA测序人类IPF和健康供体AEC2s,和小鼠AEC2s在白素损伤后.
- 对与脂质代谢相关的基因的途径分析.
- 免疫光染色和流动细胞计量以评估细胞脂质含量.
- 用3D有机体培养来评估AEC2原始体功能与脂质补充和PPARγ激活.
主要成果:
- 脂质代谢基因在IPF AEC2s和受伤的小鼠AEC2s下调,老化加剧了这种影响.
- 在IPF和老年受伤的AEC2中观察到细胞脂质含量下降.
- 脂质补充和PPARγ激活在体外增强了AEC2原体的更新,增殖和SFTPC表达.
结论:
- 在AEC2中的脂质代谢缺陷是IPF和与衰老相关的肺损伤的关键特征.
- 在AEC2中恢复脂质稳定可以增强它们的原始功能.
- 准AEC2脂质代谢是IPF的一种有前途的治疗策略.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:05Breathing
59.2K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.2K
01:21Acute Respiratory Failure-II
218
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:23Cystic Fibrosis: Pathogenesis
224
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
224
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K